CHPA Educational Foundation names new chairman
The CHPA Educational Foundation board of directors on Wednesday elected Stephen Neumann as its new chairman. Neumann is a long-time foundation board member and serves as vice president, consumer insights and business intelligence for Bayer Consumer Health.
Neumann succeeds Christopher DeWolf, president and CEO, Lil’ Drug Store Products, who was the foundation’s chair for the past two years.
“I want to thank Chris for standing at the helm of the foundation, leading us through a time of great change. We are delighted he will be staying on the board,” Anita Brikman, executive director of the CHPA Educational Foundation, said. “I am thrilled for Steve to take on his new role as chair. We look forward to his leadership in helping the foundation to grow and advance its strategic priorities.”
“I am excited to take on this new leadership role with the foundation,” Neumann said. “Our board is filled with knowledgeable and dynamic consumer healthcare leaders, and I look forward to working with them to help advance the foundation’s vision of helping consumers lead healthier, happier lives through responsible self-care.”
At the foundation board meeting during CHPA’s Annual Executive Conference, held March 11-14, 2018, at Turnberry Isle Miami, Fla., the foundation also elected two new board members, including Amardeep Kahlon, chief marketing officer, commercial North America, GSK Consumer Healthcare, and Kyle Stenzel, senior vice president, sales, North America, Combe.
In addition to Neumann, Kahlon and Stenzel, other members of the CHPA Educational Foundation board of directors include DeWolf; Morris Lewis, senior director, corporate affairs lead, Pfizer Consumer Health; Scott Melville, president and CEO, Consumer Healthcare Products Association; Ryan Olohan, managing director, healthcare, Google; Joy-Lee Pasqualoni, consumer communication leader – North America, Johnson & Johnson Consumer; and David Tomasi, commercial director, North America personal health care, Procter & Gamble.
The CHPA Educational Foundation’s mission is to be the trusted source of information on the responsible use of consumer healthcare products including over-the-counter medicines and dietary supplements.
Flu now seeing gains in the Pacific Northwest, Walgreens reports
The Pacific Northwest is now realizing significant flu activity gains according to latest Walgreens Flu Index released Wednesday.
The Seattle and Tacoma, Wash. markets led the nation in flu activity gains for the week ended March 10, according to the report, with Portland, Ore., ranking No. 3. Similarly, the greatest amount of flu activity tracked currently across the Pacific Northwest was found in the Lincoln and Hastings markets in Nebraska while Omaha, Neb., ranked No. 3.
The top 10 designated market areas as measured by flu activity gains for the week ended March 10 were:
- Seattle-Tacoma, Wash.;
- Reno, Nev.;
- Portland, Ore.;
- San Diego;
- Albany-Schenectady-Troy, N.Y.;
- Monterey-Salinas, Calif.;
- Sacramento-Stockton-Modesto, Calif.;
- San Francisco-Oakland-San Jose, Calif.;
- Lansing, Mich.; and
- Toledo, Ohio.
The top 10 designated market areas as measured by flu activity for the week ended March 10 were:
- Lincoln & Hastings-Kearney, Neb.;
- Harlingen-Weslaco-Brownsville-McAllen, Texas;
- Omaha, Neb.;
- El Paso, Texas (Las Cruces, N.M.);
- Columbia-Jefferson City, Mo.;
- Oklahoma City;
- Des Moines-Ames, Iowa;
- Corpus Christi, Texas;
- Davenport, Iowa-Rock Island-Moline, Ill.; and
- La Crosse-Eau Claire, Wis.
The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. The Flu Index provides insight by showing which cities or metropolitan areas are experiencing the most incidences of influenza each week based on Index methodology. The data does not measure actual levels or severity of flu activity.
The Walgreens Flu Index is compiled using weekly retail prescription data for antiviral medications used to treat influenza across Walgreens and Duane Reade locations nationwide, including Walgreens locations in Puerto Rico. The data is analyzed at state and geographic market levels to measure absolute impact and incremental change of antiviral medications on a per store average basis, and does not include markets in which Walgreens has fewer than 10 retail locations.
Fitbit unveils menstrual cycle tracking with latest smartwatch
Fitbit on Tuesday unveiled the Fitbit Versa, a modern smartwatch that is preselling for $199.95 with an anticipated April 2018 release, and introduced a new menstrual cycle tracking functionality.
“As the wearables category continues to grow, Fitbit Versa fills a critical need in the market by delivering a beautifully designed, full-featured smartwatch that is easy to use at a very competitive price,” James Park, CEO of San Francisco-based Fitbit, said. “Versa brings consumers the advanced health and fitness features Fitbit is known for, along with broad compatibility across mobile platforms and four days battery life to provide users with a better picture of their overall health, making it stand out from any smartwatch available today.”
Fitbit is touting the new entry as the lightest metal smartwatch on the U.S. market with advanced health tracking features including 24/7 heart rate tracking, onscreen workouts an automatic sleep stages tracking. In addition, the smartwatch enables wallet-free payments on Fitbit Versa Special edition and carries on-device music with four days of battery life.
Fitbit also announced a new menstrual cycle tracking feature to help users keep track of their menstrual cycle, view holistic health data in one place and better understand connections to their overall health, Fitbit said.
The feature offers users “a greater understanding of their menstrual cycles in conjunction with their physical and mental health, as they start to recognize what are normal trends over time vs. what could be an issue to share with their doctor,” Katharine White, assistant professor of obstetrics and gynecology at Boston University School of Medicine and Fitbit advisor. “The nuances of the menstrual cycle have not been as widely studied across population as have other areas in healthcare. This exciting development by Fitbit could help potentially create one of the largest databases of menstrual health metrics in the world, providing healthcare and research professionals with an unprecedented ability to study menstrual cycles and women’s health with real-world data.”
“I encourage all of my clients to track their activity so they understand how it plays a role in their overall health and fitness journey,” Harley Pasternak, Fitbit ambassador and celebrity trainer. “Versa offers all of the features they need in one place to stay on top of their busy days, plus it’s stylish enough that they can wear it everywhere they go — to the gym or out with friends.”